SCHEMBL136381

SCHEMBL136381

Cc1ccc(C(=O)c2c(-c3ccccc3)csc2N)cc1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
PRKCZ Q05513 7/20 0.61
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
LMNA P02545 3/20 0.61
HPGD P15428 2/20 0.61
MAPT P10636 5/20 0.59
HSD17B10 Q99714 4/20 0.59
TSHR P16473 1/20 0.59
MAPK1 P28482 1/20 0.59
GRM6 O15303 1/20 0.48
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
AKR1C3 P42330 1/20 0.44
GRIN2C Q14957 1/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PRKCI P41743 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3980970 0.89 ALDH1A1 (0.65) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL3972011 0.85 PRKCZ (0.57) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL9720150 0.82 ALDH1A1 (0.53) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL13926187 0.81 ALDH1A1 (0.70) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL26038507 0.80 PRKCZ (0.69) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL3981694 0.79 PRKCZ (0.62) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL3976107 0.79 PRKCZ (0.58) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL3976339 0.79 PRKCZ (0.58) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL3974317 0.79 PRKCZ (0.54) ALDH1A1PRKCZMEN1KMT2ALMNA
SCHEMBL1799330 0.79 KMT2A (0.69) ALDH1A1PRKCZMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2430029-B1 THIENO[2,3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2018-01-10 EP disclosed
US-9499563-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2016-11-22 US disclosed
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS CISTIM LEUVEN VZW (BE) 2014-10-02 US disclosed
US-8785638-B2 Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2014-07-22 US disclosed
EP-2430029-A1 THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven (BE) 2012-03-21 EP disclosed
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2012-03-08 US disclosed
WO-2010130842-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296272-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885PRKCZ 3925/4885MEN1 4548/4885
US-20120059028-A1 THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS TYMP, DUT, MAVS ALDH1A1 1925/4885PRKCZ 3925/4885MEN1 4548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.